BOEHRINGER MANNHEIM/LILLY DIABETES CO-PROMOTION ALLIANCE
This article was originally published in The Gray Sheet
Executive Summary
BOEHRINGER MANNHEIM/LILLY DIABETES CO-PROMOTION ALLIANCE will focus on co-promotion of B-M's Accu-Chek blood glucose monitoring devices and Lilly's Humulin insulin products in the U.S. Sales forces are being trained in both product lines with the goal of integrating insulin and glucose monitoring therapies, B-M reported. Lilly said sales reps are already co-promoting the products in the field.